OptimizeRx Corp (OPRX) income statement
OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3030% below fair value
$7.31+0.37 (+5.33%)
Close on Nov 18, 2026Market cap $137.69MP/E 30.5Yield –
OptimizeRx Corp income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 73.2%
- Operating margin
- 11.1%
- Net margin
- 4.7%
- Return on equity, FY2025
- 4.2%
Financial strength
- Current ratio
- 5.58
- Debt to equity
- 0.15
- Debt to assets
- 11.6%
- Cash to current liabilities
- 248.1%
Valuation
- P/E ratio
- 30.5
- Price to sales
- 1.40
- Price to book
- 1.05
- Dividend yield
- –
See a number that looks wrong?